A paradigm shift in studies based on rheumatoid arthritis clinical registries
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, Soo-Kyung | - |
dc.contributor.author | Sung, Yoon-Kyoung | - |
dc.date.accessioned | 2021-08-02T10:53:45Z | - |
dc.date.available | 2021-08-02T10:53:45Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2019-09 | - |
dc.identifier.issn | 1226-3303 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/12563 | - |
dc.description.abstract | Clinical research is the study of aspects of patient health or illness that are closely related to clinical practice. In the late 20th and early 21th century, outcomes for patients with rheumatoid arthritis (RA) improved dramatically due to breakthroughs in new drugs. Patient-reported outcome measures now play a significant role in the drug development process as study endpoints in clinical trials of new therapies, and this has led to increased interest in the patient's perspective, drug safety and treatment outcomes in clinical practice. In accordance with these needs, many prospective cohorts for RA patients and registries of biologic disease modifying anti-rheumatic drugs have been actively conducted in the United States and European and Asian countries. A gradual shift is taking place in the major outcomes of clinical research using these prospective cohorts and registries. This article will introduce representative registries for RA in each country set up in the early 2000s and will discuss future perspectives in clinical research on RA patients using such clinical registries. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ASSOC INTERNAL MEDICINE | - |
dc.title | A paradigm shift in studies based on rheumatoid arthritis clinical registries | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Cho, Soo-Kyung | - |
dc.contributor.affiliatedAuthor | Sung, Yoon-Kyoung | - |
dc.identifier.doi | 10.3904/kjim.2018.440 | - |
dc.identifier.scopusid | 2-s2.0-85071781403 | - |
dc.identifier.wosid | 000483430700004 | - |
dc.identifier.bibliographicCitation | KOREAN JOURNAL OF INTERNAL MEDICINE, v.34, no.5, pp.974 - 981 | - |
dc.relation.isPartOf | KOREAN JOURNAL OF INTERNAL MEDICINE | - |
dc.citation.title | KOREAN JOURNAL OF INTERNAL MEDICINE | - |
dc.citation.volume | 34 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 974 | - |
dc.citation.endPage | 981 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002494311 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | NECROSIS-FACTOR INHIBITORS | - |
dc.subject.keywordPlus | PATIENT-REPORTED OUTCOMES | - |
dc.subject.keywordPlus | QUALITY-OF-LIFE | - |
dc.subject.keywordPlus | SERIOUS INFECTION | - |
dc.subject.keywordPlus | DISEASE-ACTIVITY | - |
dc.subject.keywordPlus | BRITISH-SOCIETY | - |
dc.subject.keywordPlus | FACTOR THERAPY | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | PSORIATIC-ARTHRITIS | - |
dc.subject.keywordPlus | BIOLOGICS | - |
dc.subject.keywordAuthor | Cohort studies | - |
dc.subject.keywordAuthor | Registries | - |
dc.subject.keywordAuthor | Patients reported outcomes | - |
dc.subject.keywordAuthor | Big data | - |
dc.subject.keywordAuthor | Arthritis, rheumatoid | - |
dc.identifier.url | https://www.kjim.org/journal/view.php?doi=10.3904/kjim.2018.440 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.